Literature DB >> 24660834

Echocardiography-based hemodynamic management of left ventricular diastolic dysfunction: a feasibility and safety study.

Sasha K Shillcutt1, Candice R Montzingo, Ankit Agrawal, Maseeha S Khaleel, Stacey L Therrien, Walker R Thomas, Thomas R Porter, Tara R Brakke.   

Abstract

BACKGROUND: Patients with left ventricular diastolic dysfunction (LVDD) are at increased risk of postoperative adverse events. The primary aim of this study was to evaluate the safety and feasibility of using echocardiography-guided hemodynamic management (EGHEM) during surgery in subjects with LVDD compared to conventional management. The feasibility of using echocardiography to direct a treatment algorithm and clinical outcomes were compared for safety between groups.
METHODS: Subjects were screened for LVDD by preoperative transthoracic echocardiography (TTE) and randomized to the conventional or EGHEM group. Subjects in EGHEM received hemodynamic management based on left ventricular filling patterns on transesophageal echocardiography (TEE). Primary outcomes measured were the feasibility to obtain TEE images and follow a TEE-based treatment algorithm. Safety outcomes also compared the following clinical differences between groups: length of hospitalization, incidence of atrial fibrillation, congestive heart failure (CHF), myocardial infarction, cerebrovascular accident, transient ischemic attack and renal failure measured 30 days postoperatively.
RESULTS: Population consisted of 28 surgical subjects (14 in conventional group and 14 in EGHEM group). Mean subject age was 73.4 ± 6.7 years (36% male) in conventional group and 65.9 ± 14.4 years (36% male) in EGHEM group. Procedures included orthopedic (conventional = 29%, EGHEM 36%), general (conventional = 50%, EGHEM = 36%), vascular (conventional = 7%, EGHEM = 21%), and thoracic (conventional = 14%, EGHEM = 7%). There was no statistically significant difference in adverse clinical events between the 2 groups. The EGHEM group had less CHF, atrial fibrillation, and shorter length of stay.
CONCLUSIONS: Echocardiography-guided hemodynamic management of patients with LVDD during surgery is feasible and may be a safe alternative to conventional management.
© 2014, Wiley Periodicals, Inc.

Entities:  

Keywords:  anesthesia; atrial fibrillation; congestive heart failure; elderly; left ventricular diastolic dysfunction; transesophageal echocardiography; transthoracic echocardiography

Mesh:

Year:  2014        PMID: 24660834     DOI: 10.1111/echo.12574

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  5 in total

1.  Transesophageal Versus Transthoracic Echocardiography for Assessment of Left Ventricular Diastolic Function.

Authors:  Theingi Tiffany Win; Ihab B Alomari; Khaled Awad; Michelle D Ratliff; Clifford R Qualls; Carlos A Roldan
Journal:  J Integr Cardiol       Date:  2020-02-18

2.  TAPB and RSB protects cardiac diastolic function in elderly patients undergoing abdominopelvic surgery: a retrospective cohort study.

Authors:  Chao Gong; Shitong Li; Xiaojing Huang; Lianhua Chen
Journal:  PeerJ       Date:  2020-07-02       Impact factor: 2.984

Review 3.  Heart Failure With Preserved Ejection Fraction: A Perioperative Review.

Authors:  Sasha K Shillcutt; M Megan Chacon; Tara R Brakke; Ellen K Roberts; Thomas E Schulte; Nicholas Markin
Journal:  J Cardiothorac Vasc Anesth       Date:  2017-08-30       Impact factor: 2.628

Review 4.  Perioperative transesophageal echocardiography for non-cardiac surgery.

Authors:  Ashraf Fayad; Sasha K Shillcutt
Journal:  Can J Anaesth       Date:  2017-11-17       Impact factor: 5.063

5.  Goal-directed haemodynamic therapy during general anaesthesia for noncardiac surgery: a systematic review and meta-analysis.

Authors:  Marie K Jessen; Mikael F Vallentin; Mathias J Holmberg; Maria Bolther; Frederik B Hansen; Johanne M Holst; Andreas Magnussen; Niklas S Hansen; Cecilie M Johannsen; Johannes Enevoldsen; Thomas H Jensen; Lara L Roessler; Peter C Lind; Maibritt P Klitholm; Mark A Eggertsen; Philip Caap; Caroline Boye; Karol M Dabrowski; Lasse Vormfenne; Maria Høybye; Jeppe Henriksen; Carl M Karlsson; Ida R Balleby; Marie S Rasmussen; Kim Pælestik; Asger Granfeldt; Lars W Andersen
Journal:  Br J Anaesth       Date:  2021-12-13       Impact factor: 11.719

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.